Drug factory · FDA FEI 3002806964
Farmhispania S.A.
Passeig Riu Besos, 9-10, Montmelo, Spain
Problems found, fixed voluntarily at FDA's last inspection, May 12, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2009: 0 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Canagliflozin and Metformin | Makes the active ingredient and tests it | Janssen Pharmaceuticals, Inc. | 50458-540, 50458-541, 50458-542 +5 |
| Metformin and Pioglitazone | Makes the active ingredient | Takeda Pharmaceuticals America, Inc. | 64764-158 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| May 12, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 16, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 15, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 12, 2012 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Apr 29, 2009 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.